All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@findingkerryagain's Ozempic dosing walkthrough, fact-checked

Finding Kerry

TikTok creator

70.1K viewsWatch on TikTok→

Quick answer

The creator is following a standard semaglutide initiation protocol, using the recommended 0.25 mg weekly starting dose before escalating to 0.5 mg at week five, consistent with the FDA-approved Ozempic dosing schedule. The hashtag use of #compoundsemaglutide alongside #ozempic introduces uncertainty about whether the product shown is a regulated branded pen or a compounded formulation, which carry different regulatory and quality assurance considerations. Injection technique is largely appropriate, though the described two-week site alternation interval is less frequent than most clinical guidance recommends for preventing lipohypertrophy.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @findingkerryagain actually say?

This video is a straightforward injection walkthrough. The creator demonstrates their third semaglutide dose, describes "clicking it to 0.25" milligrams, attaches a new needle tip, swabs the injection site with alcohol, removes the needle cap, grabs stomach tissue, injects, and holds for six extra seconds after hearing the click. No dramatic weight-loss claims. No medical advice given to viewers. Just someone showing their process.

The hashtags tell a slightly more complicated story. Tags like #compoundsemaglutide alongside #ozempic suggest the creator may be using a compounded version rather than the branded Ozempic pen, though they never state this explicitly on camera. That distinction matters clinically, even if the injection technique looks nearly identical.

Does the science back this up?

Most of what they demonstrate is consistent with standard subcutaneous injection protocol. The 0.25 mg starting dose aligns exactly with the FDA-approved Ozempic prescribing information, which recommends 0.25 mg weekly for the first four weeks as a tolerability ramp, not a therapeutic dose. The post-injection hold is also supported in practice.

The SUSTAIN clinical trial program (Marso et al., 2016, New England Journal of Medicine) established the 0.25 mg to 0.5 mg escalation schedule that became standard practice. The rationale is minimizing gastrointestinal side effects, not maximizing weight loss, at the lowest dose. Holding the pen after injection reduces the risk of medication leaking back out of the injection site, a small but real concern with subcutaneous biologics. Alcohol swabbing is widely practiced, though evidence that it reduces infection risk in home self-injection settings is actually weaker than most people assume.

What did they get wrong (or right)?

Credit where it is due: the technique itself is largely correct. New needle for each injection, alcohol prep, alternating injection sides, confirming the dose dial, holding post-click. These are all things a lot of people skip or do sloppily, and the creator does them properly.

Two things worth flagging. First, they say "I switch sides every second week." Standard guidance from most clinical protocols, including Novo Nordisk's own patient education materials, recommends rotating injection sites within the same region each week, not waiting two weeks between sides. Injecting the same area repeatedly can cause lipohypertrophy, a localized buildup of fatty tissue that impairs drug absorption. Rotating more frequently reduces that risk.

Second, the creator is on what they describe as their "last .25g dose" before moving to 0.5 mg. The notation mixing "g" and "mg" is worth noting for anyone watching. Semaglutide is dosed in milligrams, not grams. 0.25 grams would be 250 milligrams, which is an entirely different and dangerous quantity. This is almost certainly a typo in the caption, not a real error in practice, but these things get copied by viewers who are newer to injections.

What should you actually know?

The injection technique shown here is a reasonable template for beginners, with the rotation caveat above. But the bigger context is what this video does not address. The hashtag #compoundsemaglutide raises a real issue. Compounded semaglutide is not the same product as FDA-approved Ozempic or Wegovy. The FDA has issued multiple warnings about compounded semaglutide, including concerns about dosing errors, sterility, and the use of semaglutide salt forms rather than the base form used in approved drugs (FDA Drug Safety Communication, 2024).

If this creator is using a compounded product, the pen mechanism shown may differ from what viewers using other compounded formulations will encounter, since many compounded semaglutide products come in vials requiring separate syringes, not auto-injector pens. Viewers should not assume their setup matches what is shown here without confirming with their prescriber or pharmacist.

The 0.25 mg to 0.5 mg escalation shown is consistent with evidence-based titration. But dose decisions belong between a patient and a licensed clinician, not in a comment section or a TikTok caption.

Bottom line

This is one of the more technically responsible injection tutorials on GLP-1 TikTok. The creator is not making outrageous claims, not claiming to cure anything, and is demonstrating genuine care for doing this correctly. The rotation frequency advice could use adjustment, and the gram-versus-milligram notation in the caption is a real potential confusion point for a 70,000-view video. The compounded versus branded ambiguity is the most clinically significant unaddressed issue in the whole thing.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @findingkerryagain's Ozempic dosing walkthrough, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Claim verdict

The useful answer behind this video

Claim being checked

The creator is following a standard semaglutide initiation protocol, using the recommended 0.

FormBlends verdict

The creator is following a standard semaglutide initiation protocol, using the recommended 0.25 mg weekly starting dose before escalating to 0.5 mg at week five, consistent with the FDA-approved Ozempic dosing schedule. The hashtag use of #compoundsemaglutide alongside #ozempic introduces uncertainty about whether the product shown is a regulated branded pen or a compounded formulation, which carry different regulatory and quality assurance considerations. Injection technique is largely appropriate, though the described two-week site alternation interval is less frequent than most clinical guidance recommends for preventing lipohypertrophy.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is following a standard semaglutide initiation protocol, using the recommended 0.25 mg weekly starting dose before escalating to 0.5 mg at week five, consistent with the FDA-approved Ozempic dosing schedule. The hashtag use of #compoundsemaglutide alongside #ozempic introduces uncertainty about whether the product shown is a regulated branded pen or a compounded formulation, which carry different regulatory and quality assurance considerations. Injection technique is largely appropriate, though the described two-week site alternation interval is less frequent than most clinical guidance recommends for preventing lipohypertrophy.
  • The 0.25 mg weekly starting dose is not a therapeutic weight-loss dose. The SUSTAIN-1 trial (Sorli et al., 2017, Lancet Diabetes and Endocrinology) showed meaningful glycemic and weight effects begin at 0.5 mg and above.
  • Injection site rotation should happen every injection, not every two weeks. Repeated injection into the same spot can cause lipohypertrophy, which reduces drug absorption unpredictably.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The 0.25 mg weekly starting dose is not a therapeutic weight-loss dose. The SUSTAIN-1 trial (Sorli et al., 2017, Lancet Diabetes and Endocrinology) showed meaningful glycemic and weight effects begin at 0.5 mg and above.
  • Injection site rotation should happen every injection, not every two weeks. Repeated injection into the same spot can cause lipohypertrophy, which reduces drug absorption unpredictably.
  • The caption mixes 'g' and 'mg' notation. Semaglutide is dosed in milligrams. 0.25 g would equal 250 mg, a potentially dangerous misread for new injectors copying this format.
  • The FDA issued a 2024 safety communication warning that compounded semaglutide products may use different salt forms than approved drugs, which affects potency calculations and safety profiles.
  • Compounded semaglutide is not equivalent to branded Ozempic or Wegovy under FDA standards. Viewers should not assume identical handling, dosing, or pen mechanisms across products.
  • Post-injection holds of 5 to 10 seconds are supported by device guidance for subcutaneous auto-injectors and reduce the small but real risk of drug leaking back through the injection track.
  • Alcohol swabbing before self-injection is standard practice, but evidence from Sutherland et al. (2014, Diabetic Medicine) suggests it adds limited infection-prevention benefit in clean home settings.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Finding Kerry · TikTok creator

70.1K views on this video

Here i am awkwardly explaining the step by step of my third ozempic injection. This is week 3 and my last .25g dose. I move up to .5mg next Tuesday! #ozempicjourney #ozempic #ozempicbeforeandafter #o

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Finding Kerry, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.